Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
NRx Pharmaceuticals
NRx Pharmaceuticals Overview
NeuroRX is a specialized CNS biopharma company, resolutely focused on meeting very high unmet medical needs for those with severe bipolar depression with suicidality and post-traumatic stress disorder (PTSD).
The company growing pipeline is powered by its proprietary, dual-targeted mechanism of action, which safely modulates the NMDA and 5HT2A receptors. Its mission is to bring hope to people with life-threatening diseases through breakthrough science.
NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock
#Public Trading #Investment
Apr 18, 2024
finance.yahoo.com
NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement
#Customers #Partners #Public Trading
Apr 17, 2024
finance.yahoo.com
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections
#Investment #Partners
Apr 17, 2024
finance.yahoo.com
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
#Public Trading #Investment
Apr 15, 2024
finance.yahoo.com
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)
NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock
#Public Trading #Investment
Apr 18, 2024
finance.yahoo.com
NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement
#Customers #Partners #Public Trading
Apr 17, 2024
finance.yahoo.com
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections
#Investment #Partners
Apr 17, 2024
finance.yahoo.com
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
#Public Trading #Investment
Apr 15, 2024
finance.yahoo.com
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)
#Partners #Investment
View other companies you might be interested in
NRx Pharmaceuticals Team
No Data, yet.
Sorry, no content found under this section.
View other companies you might be interested in
Connect with
What is the reason for connecting? *
Your company *
Company website (recommended)
Please enter a valid website
Your organization type *
Please enter a valid organization type
Your position *
Add invitation message
0/300
Sending invitation...
Invitation sent
You will be able to start a conversation once [Name] accepts it.